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Lipoprotein Lp(a) represents an independent risk factor for cor-
onary artery disease (CAD). However, its association with CAD
burden and lipid rich plaques prone to rupture in patients with
acute coronary syndrome (ACS) still remains unknown. These data
aim to investigate the association among serum Lipoprotein(a)
(Lpa) levels, coronary atherosclerotic burden and features of cul-
prit plaque in patients with ACS and obstructive CAD. For his
reason, a total of 500 ACS patients were enrolled for the angio-
graphic cohort and 51 ACS patients were enrolled for the optical
coherence tomography (OCT) cohort. Angiographic CAD severity
was assessed by Sullivan score and by Bogaty score including
stenosis score and extent index, whereas OCT plaque features were
evaluated at the site of the minimal lumen area and along the
culprit segment. In the angiographic cohort, Lp(a) was a weak
independent predictor of Sullivan score (po0.0001), stenosis
score (po0.0001) and extent index (po0.0001). In the OCT
cohort, patients with higher Lp(a) levels (430 md/dl) compared tovier Inc. This is an open access article under the CC BY license
/j.atherosclerosis.2016.01.020
li).
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G. Niccoli et al. / Data in Brief 7 (2016) 1409–14121410patients with lower Lp(a) levels (o30 md/dl) exhibited a higher
prevalence of lipidic plaque at the site of the culprit stenosis
(P¼0.02), a wider lipid arc (p¼0.003) and a higher prevalence of
thin-cap ﬁbroatheroma (p¼0.004)
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Medical Clinical Research
ore speciﬁc sub-
ject areaCoronary Intervention; Angiography; Intra-coronary Imaging; lipidsype of data Figure
ow data was
acquiredBlood samplingata format Analyzed
xperimental
factorsVenous blood samples were drawn and then centrifuged in appropriate tubes;
aliquots of serum were stored at 80 °C until assayed.xperimental
featuresLipoprotein(a) was assessed with a test immuno-turbidimetric boosted with
particles: human LPA agglutinates latex particles coated with antibodies to
Lipoprotein(a); the precipitate is determined turbidimetrically at 552 nm.ata source
locationPoliclinico Gemelli, Rome, Italy; Sant Andrea hospital, Rome, Italyata accessibility The data is with this articleD
Value of the data
 These data prime prospective studies designed in order to address the effect of lipid lowering drugs on
Lipoprotein(a) (Lpa) value.
 These data may prime future studies addressing the role of therapies targeting Lp(a) in the reduction of
vulnerable plaque features of patients with coronary artery disease (CAD).
 These data may prime multicenter evaluation of the association between optical coherence tomography
(OCT) features and Lp(a) values.1. Data
These data exhibit a positive correlation between Lp(a) levels and coronary atherosclerotic burden
assessed by angiography in patients with acute coronary syndrome (ACS) (Sullivan Score R2¼0.35,
po0.0001; Stenosis score R2¼0.21, po0.0001); Extent index (R2¼0.24, po0.0001).
Moreover, patients with Lp(a) levels430 md/dl compared to patients with Lp(a) levelso30 md/dl
exhibited a higher prevalence of lipidic plaque at the site of the culprit stenosis (67% vs. 27%; P¼0.02)
(Fig. 1), a wider lipid arc (1357114 vs. 597111; P¼0.03) and a higher prevalence of thin-cap
ﬁbroatheroma (38% vs. 10%; P¼0.04) (Fig. 1).2. Experimental design, materials and methods
A total of 500 patients (370 men, average age 66711) with ACS were prospectively enrolled for
the angiographic evaluation of CAD severity with Sullivan score and by Bogaty score including
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rospectively included for OCT examination.
In order to investigate the features of coronary atherosclerosis in patients with normal vs.
abnormal Lp(a), angiographic and OCT cohort were divided in two groups: those with Lp(a)
valueso30 mg/dl and those with Lp(a)Z30 mg/dl.
Statistical analysis: A multiple linear regression was performed to assess independent predictors of
the angiographic scores.
2.1. Angiographic analysis
Two expert angiographers, blinded to the laboratory values, evaluated all angiographic images to
assess presence, severity and extent of CAD. Any disagreement between the two angiographers was
resolved by consensus; when consensus could not be reached, a third experienced angiographer
assessed and classiﬁed the coronary lesions.
The Bogaty's score assesses disease severity and extent. Severity of disease refers to the total
number of Z50% narrowings in all vessels of the angiogram. A maximum of three stenoses was
permitted per coronary arterial segment. Extent of disease is obtained by dividing the extent score of
the entire coronary arterial tree by the number of analyzed segments. A segment is scored 0 if it
appeared angiographically normal, 1 if r10% of its length appeared abnormal, 2 if 410% up to 50% of
its length was abnormal, and 3 if 450% of its length was abnormal. Since there were 15 segments
considered, the extent index could vary from 0 to 3.
Stenosis score refers to the most severe stenosis observed in each main coronary artery branch.
Grading is as follows: grade (1) 1–49% reduction in coronary lumen diameter; grade (2) stenosis with
50–74% reduction in lumen diameter; grade (3) stenosis with 75–99% reduction in lumen diameter;
and grade (4) total coronary occlusions. The score is obtained by the sum of the results in each main
coronary vessel (maximal value 32, if all eight main coronary artery branches have grade 4).
The extent score refers to the proportion of the coronary artery tree showing angiographically
detectable atheroma. The observed proportion in each vessel is multiplied by a factor that varies
according to the artery involved: left main stem, 5; left anterior descending coronary artery, 20; main
diagonal branch, 10; ﬁrst septal perforator, 5; left circumﬂex artery, 20; obtuse marginal and postero-
lateral vessels, 10; right coronary artery, 20; and main posterior descending branch, 10. When the
major lateral wall branch was a large obtuse marginal or intermediate vessel, this was given a factor
of 20, and the left circumﬂex artery, a factor of 10. When a vessel was occluded and the distal bed wasFig. 1. The prevalence of lipidic plaque and thin-cap ﬁbroatheroma (TCFA) in the patients with high Lipoprotein(a) (Lpa) value
vs. those with low Lipoprotein(a) value.
G. Niccoli et al. / Data in Brief 7 (2016) 1409–14121412not fully visualized by collateral ﬂow, the proportion of vessel not visualized was given the mean
extent score of the remaining vessels. The scores for each vessel or branch were added to give a total
score (maximal value¼100); this total score represents an estimate of the percentage of the coronary
luminal surface area involved by atheroma.
2.2. Frequency domain-optical coherence tomography (FD-OCT) analysis
FD-OCT analysis was divided into two parts: the analysis performed at minimal lumen area (MLA) site
and the analysis conducted along the culprit vessel. FD-OCT analysis was performed at MLA site. OCT
analysis was targeted on plaque characterization, presence of plaque rupture, ﬁbrous cap thickness,
presence of thin-cap ﬁbro-atheroma, presence of intracoronary thrombus and minimal lumen area.
Plaques assessed at the site of minimal lumen area were classiﬁed as lipidic, ﬁbrous or calciﬁed plaques.
Lipid pool was deﬁned as homogenous, diffusely bordered, signal-poor regions with overlying signal-rich
bands. Fibrous plaques were deﬁned as homogeneous high signal regions. Calciﬁed plaques were deﬁned
as heterogeneous or signal poor regions with sharply delineated borders. Plaque rupture was deﬁned as
the presence of ﬁbrous cap discontinuity leading to a communication between the inner necrotic core of
the plaque and the lumen, with or without the presence of a ﬂap. Thin-cap ﬁbroatheroma was deﬁned as
a lipid-rich plaque with a ﬁbrous cap thickness of r65 mm. Intra-coronary thrombus was deﬁned as an
irregular mass protruding into the lumen or adjacent to the luminal surface. Microchannels were deﬁned
as non-signal tubule-luminal structures without a connection to the vessel lumen, recognized on more
than three consecutive cross-sectional OCT images.
2.3. Statistical analysis
Continuous variables between the two groups of subjects in the study population (Lpo30 mg/dl and
LpZ30 mg/dl) were compared with unpaired t-test or Mann–Whitney U-test. Categorical variables were
compared using the chi square test or Fisher's exact test, as appropriate. Correlations between variables
were performed using the Pearson test or the Spearman's rank test, as appropriate. A multiple linear
regression was performed to assess independent predictors of the Bogaty and Sullivan score. In the
univariate model, we included the overall clinical and angiographic variable considered. On the other
hand, in the multiple regression analysis model, we included all variables showed in the univariate except
drugs. In particular, in the linear regression, analyses with stepwise variable selection were applied to
assess independent correlates of stenosis, Sullivan and Extend score. Covariates were all clinical and
angiographic variables. In order to address skewed data, logarithmic transformation was applied directly
from the software. Studies have shown that values greater than 30 mg/dL are considered abnormal.
Po0.05 was always required for statistical signiﬁcance.Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.04.017.
